|
× |
 |
DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
ERAXIS (anidulafungin) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
EVRYSDI (risdiplam) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
× |
 |
EDURANT (rilpivirine hydrochloride) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
|
|